Skip Navigation

European Heart Journal 2004 25(15):1310-1317; doi:10.1016/j.ehj.2004.05.011
Copyright © 2004 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ballo, P.
Right arrow Articles by Faraguti, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballo, P.
Right arrow Articles by Faraguti, S. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Clinical research

Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia

Piercarlo Ballo*, Daniele Bernabò and Sergio Antonio Faraguti

Department of Cardiology, S. Andrea Hospital, La Spezia, Italy

* Corresponding author. Tel.: +39-0187-53255/299; fax: +39-0187-533456
E-mail address: pcballo{at}tin.it

Received 24 July 2003; revised 21 April 2004; accepted 13 May 2004 See page 1277 for the editorial comment on this article1

Abstract

Aims To analyse whether heart rate may affect the efficacy of adenosine, verapamil and carotid sinus massage in terminating symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) in adults.

Methods and results The study population was selected among 175 adult patients, affected by symptomatic PSVT. One hundred and six of them were considered eligible for the study. Each subject received one of the following treatments: verapamil, 5 mg intravenously (IV) in 5–10 min, followed by 1–5 µg/kg/min; adenosine, 6 mg IV, followed by 12 mg IV after 2–3 min; carotid sinus massage. Adenosine and verapamil were similarly effective in terminating PSVT (74.4% vs 81.8%, ). The efficacy of carotid sinus massage was significantly lower in comparison with the other two groups (32.4%, vs adenosine and vs verapamil group). At logistic regression, PSVT rate showed a positive association with the percentage of sinus rhythm restoration in the group who received adenosine (). The probability of success in resolving the tachycardia following treatment with adenosine was 75% for heart rates over 166 beats per minute (bpm), but rapidly decreased at lower frequencies, reducing to 25% at 138 bpm. In the verapamil group, PSVT rate was negatively related to the percentage of sinus rhythm restoration (). The probability of success in terminating PSVT following administration of verapamil was 75% for heart rates lower than 186 bpm, but tended to decrease at faster rates, reducing to 25% at 241 bpm. No significant effects of heart rate were observed in the carotid sinus massage group (). The probability curves obtained in the adenosine and verapamil group crossed at a point corresponding to 173 bpm, which may represent a cut-off value to predict which treatment could ensure higher rate of success.

Conclusions Heart rate predicts restoration of sinus rhythm in adult subjects with symptomatic episodes of PSVT treated with adenosine and verapamil. Adenosine is highly effective in PSVT characterised by fast rates, whereas the efficacy of verapamil is increased in patients with low-frequency PSVT.

Key Words: Adenosine • Verapamil • Vagal manoeuvres • Heart rate • Supraventricular tachycardia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia?
Gerhard Steinbeck and Christopher Reithmann
EHJ 2004 25: 1277-1278. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
Eur Heart JHome page
G. Steinbeck and C. Reithmann
Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia?
Eur. Heart J., August 1, 2004; 25(15): 1277 - 1278.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.